A system for lead integrity monitoring includes an implantable medical device (IMD) having a housing enclosing a control circuit; and a lead, having a first sensor. The lead is coupled to the housing and electrically coupled to the control circuit. The system also includes at least one processing device configured to identify a first lead failure alert based on a first set of information; obtain a second set of information generated by a second sensor; perform an evaluation of the first set of information in the context of the second set of information; and confirm or cancel the first lead failure alert based on the evaluation.

An electrical stimulator is provided that is capable of easily detecting an electrical connection defect. An electrical stimulator 1 includes an electrode group 10 having three or more electrodes and a driving means 20 that gives energy to the electrode group 10. Under the condition that one electrode of the electrode group 10 is set as a first polarity and that the remaining plurality of electrodes are each set as a second polarity, the driving means 20 is configured to give energy to the electrode group 10 while performing switching among the electrodes each of which is set as the first polarity in turn. The electrical stimulator 1 additionally includes a connection-defect detection means 30 that detects an electrical connection defect by detecting whether electrical stimulation has been applied to a user when energy is given to the electrode group 10.

A medical device system and method for detecting dislodgement of a ventricular lead determines one or more characteristics of a cardiac signal received via the ventricular lead that are associated with dislodgement of the ventricular lead during atrial fibrillation, and detects dislodgement of the ventricular lead based on the determined characteristics. The medical device and system provides a lead dislodgment alert in response to detecting dislodgement. In some examples, an implantable medical device withholds delivery of a ventricular defibrillation therapy based on detecting dislodgement of the ventricular lead.

A patch for a therapeutic electrical stimulation device includes a shoe connected to the first side of the patch, the shoe including a body extending in a longitudinal direction from a first end to a second end, and having first and second surfaces, the first end of the shoe defining at least two ports, and the first surface of the shoe defining a connection member. The patch also includes at least one conductor positioned in the ports of the first end of the shoe. The shoe is configured for sliding insertion into a receptacle defined by a controller so that the conductor is connected to the controller to deliver electrical current from the controller, through the conductor, and to the electrodes, and the connection member is at least partially captured by a detent defined by the controller in the receptacle to retain the shoe within the receptacle.

A method and system for providing stimulation to a user, the method including: transitioning a stimulation device from a baseline state to a first impedance monitoring state; during the first impedance monitoring state, guiding, an adjustment of a position of the stimulation device at a head region of the user to satisfy a first impedance criterion; upon satisfaction of the first impedance criterion, transitioning the stimulation device from the first impedance monitoring state to a stimulation regime that comprises a second monitoring state having a second criterion; upon detection of failure to satisfy the second criterion, transitioning the stimulation device from the stimulation regime to the first impedance monitoring state; and upon detecting that a third impedance criterion of the first impedance monitoring state is satisfied, transitioning the stimulation device from the first impedance monitoring state to the stimulation regime.

A method and system for providing stimulation to a user, the method including: transitioning a stimulation device from a baseline state to a first impedance monitoring state; during the first impedance monitoring state, guiding, an adjustment of a position of the stimulation device at a head region of the user to satisfy a first impedance criterion; upon satisfaction of the first impedance criterion, transitioning the stimulation device from the first impedance monitoring state to a stimulation regime that comprises a second monitoring state having a second criterion; upon detection of failure to satisfy the second criterion, transitioning the stimulation device from the stimulation regime to the first impedance monitoring state; and upon detecting that a third impedance criterion of the first impedance monitoring state is satisfied, transitioning the stimulation device from the first impedance monitoring state to the stimulation regime.

An exemplary electrode locating system performs an excitation spread measurement by directing a first electrode to generate an electrical pulse and, in response to the generation of the electrical pulse, detecting a voltage between a second electrode and a reference that are both distinct from the first electrode. The first and second electrodes are included in a plurality of electrodes disposed on an electrode lead included within a cochlear implant system and that comprises a proximal portion configured to be coupled with a cochlear implant and a distal portion configured to be inserted into a cochlea of a patient by way of an insertion procedure. Based on the excitation spread measurement, the electrode locating system determines whether at least one of the first electrode and the second electrode is located within the cochlea. Corresponding methods are also described.

A lead impedance stimulation architecture and a dual current source and sink methodology to output a biphasic current pulse and measure a resulting induced voltage across the stimulation electrodes to determine lead impedance. A common mode capacitance on the electrode interface may have little impact on the stimulation architecture of this disclosure allowing for fast voltage rise time and consistent and accurate impedance measurement. In addition, the dual source and sink includes a monitor circuit on each of the source and the sink circuitry. In the event of an open circuit indicating a lead breakage, loose connection, lead migration, insulation leak, and so on, the monitor circuit may provide an output to indicate specifically which electrode is unable to reach the correct current stimulation amplitude. In this manner the techniques of this disclosure, may also detect a lead break in a single lead impedance measurement.

Described is a low voltage, pulsed electrical stimulation device for upregulating expression of klotho, a useful protein, by tissues. Also described are methods of enhancing expression of klotho in cells.

Embodiments are directed to an implantable medical device comprising therapeutic stimulation circuitry for controlling delivery of a medical therapy to a patient, the therapeutic stimulation circuitry having at least one lead having electrodes for delivering the medical therapy, The implantable medical device further comprises measurement circuitry for determining characteristics of the at least one lead, a processor for controlling the IMD according to executable code, and memory for storing data and executable code, wherein the executable code comprises instructions for causing the processor to receive a plurality of voltage measurements associated with the electrodes, and calculate values for an impedance model of the electrode/tissue interface.